Is tenofovir disoproxil fumarate an all-powerful weapon in the treatment of chronic hepatitis B?
Is tenofovir disoproxil fumarate an all-powerful weapon in the treatment of chronic hepatitis B?
- 발행기관 대한내과학회
- 발행년도 2015
- 총서유형 Journal
- UCI G704-001640.2015.30.1.014
- KCI ID ART001956104
- 본문언어 영어
초록/요약
In conclusion, while TDF-based therapy is a promisingapproach and is currently the best option in themanagement of CHB patients with antiviral resistance,we do not have sufficient data to conclude that TDF isthe all-powerful drug suggested by some studies. Longtermfollow-up data from well-designed trials will allowphysicians to select the best therapeutic options fortheir patients with antiviral-resistant CHB.
more